300 related articles for article (PubMed ID: 29754146)
1. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
Gao Z; Shi R; Yuan K; Wang Y
Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
4. Expressions and prognostic values of the
Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
[No Abstract] [Full Text] [Related]
5. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Li Y; Huang J; Yang D; Xiang S; Sun J; Li H; Ren G
Oncol Lett; 2018 Jun; 15(6):9216-9230. PubMed ID: 29844824
[TBL] [Abstract][Full Text] [Related]
6. The E2F family as potential biomarkers and therapeutic targets in colon cancer.
Yao H; Lu F; Shao Y
PeerJ; 2020; 8():e8562. PubMed ID: 32117628
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.
Zhang C; Min L; Zhang L; Ma Y; Yang Y; Shou C
Tumour Biol; 2016 Feb; 37(2):2193-207. PubMed ID: 26349752
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
Luo L; Zhang G; Wu T; Wu G
Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
10. Protein expression profiles and prognostic value of E2F family members in clear cell renal cell carcinoma.
Kim YS; Jung J; Jeong H; Oh HE; Lee JH; Lee ES; Choi JW
Pathol Res Pract; 2020 Apr; 216(4):152880. PubMed ID: 32089412
[TBL] [Abstract][Full Text] [Related]
11.
Zhou Q; Zhang F; He Z; Zuo MZ
Front Oncol; 2019; 9():161. PubMed ID: 30967995
[No Abstract] [Full Text] [Related]
12. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
[TBL] [Abstract][Full Text] [Related]
13. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
Liao P; Han S; Qu H
Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer.
Li S; Yang X; Li W; Chen Z
Front Oncol; 2021; 11():625257. PubMed ID: 34532281
[TBL] [Abstract][Full Text] [Related]
15. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
Liu X; Hu C
Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
Front Oncol; 2020; 10():606735. PubMed ID: 33604289
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of
Manicum T; Ni F; Ye Y; Fan X; Chen BC
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
[TBL] [Abstract][Full Text] [Related]
18. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
19. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
20. E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.
Chen L; Yu JH; Lu ZH; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10545-54. PubMed ID: 26617764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
